World Athletics 2023 WA vs Zerfe Wondemagegn

In October 2023 the Athletics Integrity Unit (AIU), on behalf on World Athletics, reported multipe anti-doping rule violations against the Ethiopian Athlete Zerfe Wondemagegn.

The AIU established that the Athlete's samples, provided in August, in September and in November 2023, tested positive for the prohibited substances Recombinant Erythropoietin (RhEPO) and Testosterone with its metabolites.

Following notification the Athlete timely admitted the violation, waived her right for a hearing, accepted a provisional suspension and the sanction proposed by the AIU.

The Athlete explained with evidence that she underwent medical treatment in a clinic in Ethiopia and that in July 2023 EPO had been administered as treatment for her diagnosed anemia and kidney infection. Yet, she could not explain the presence of Testosterone in her sample.

The AIU deems that the Athlete failed to establish that the violation was not intentional and that there are aggravating circumstances present in this case. Because she had signed and submitted the Admission of Anti-Doping Rule Violations and Acceptance of Consequences Form she received a 1 year reduction from the AIU.

Therefore the AIU decides on 19 April 2024 to impose a 5 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 20 October 2023.

Original document

Parameters

Legal Source
Decisions International Federations
Date
19 April 2024
Original Source
Athletics Integrity Unit (AIU)
Country
Ethiopia
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acceptance of sanction
Aggravating circumstances
Circumstantial evidence
Multiple violations
Period of ineligibility
Prompt / Timely Admission
Waiver of "right to be heard"
Sport/IFs
Athletics (WA) - World Athletics
Other organisations
Athletics Integrity Unit (AIU)
Laboratories
Lausanne, Switzerland: Laboratoire Suisse d’Analyse du Dopage
Seibersdorf, Austria: Seibersdorf Labor GmbH Doping Control Laboratory
Doping classes
S1. Anabolic Agents
S2. Peptide Hormones, Growth Factors
Substances
3α-hydroxy-5α-androstan-17-one (androsterone)
5α-androstane-3α,17β-diol
5β-androstane-3α,17β-diol
Erythropoietin (EPO)
Etiocholanolone
Testosterone
Medical terms
Legitimate Medical Treatment
Document type
Pdf file
Date generated
22 April 2024
Date of last modification
25 April 2024
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin